search
Back to results

Robotic Low Rectum Anterior Resection (GROG-R01)

Primary Purpose

Rectum Cancer

Status
Active
Phase
Not Applicable
Locations
International
Study Type
Interventional
Intervention
Clinical database
Sponsored by
Institut du Cancer de Montpellier - Val d'Aurelle
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional other trial for Rectum Cancer focused on measuring cancer, rectum, robot

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  1. Men or women ≥ 18 years
  2. Introducing rectal cancer, colorectal junction eligible to robotic surgery support from June 2015
  3. Treatment Naive for this cancer
  4. Enjoying a social protection scheme (For France only)
  5. Patient followed in the participant center

Exclusion Criteria:

  1. Male or female age (s) under 18 years
  2. Private person of liberty or under supervision (including guardianship)
  3. People who do not speak French (For France only)
  4. Major Nobody unable to consent
  5. Patient GROG-R01 already included in the base
  6. Patient Refusal

Sites / Locations

  • UCL
  • Hôpital Européen
  • Institut Paoli Calmettes
  • Centre François Baclesse
  • Clinique Kennedy
  • Clinique Saint Jean du Languedoc
  • CHU Dupuytren
  • Hôpital privé d'Anthony
  • Institut régional du cancer de Montpellier
  • Hôpital Michalon
  • CHU de Nantes
  • Institut de Cancérologie de l'Ouest
  • CHR Orléans
  • CHU de Nancy
  • Centre Oscart Lambret
  • Institut Gustave Roussy
  • Hôpital Diaconesses
  • Hôpital européen Georges Pompidou
  • Centre Hospitalier-Princesse Grace

Arms of the Study

Arm 1

Arm Type

Other

Arm Label

Clinical database

Arm Description

Outcomes

Primary Outcome Measures

Conversion rate for robotic surgery

Secondary Outcome Measures

Anatomo-pathological curability criteria
Median of hospitalization time
Post-operative morbidity
Number of robot docking
Operating time

Full Information

First Posted
July 4, 2019
Last Updated
November 16, 2022
Sponsor
Institut du Cancer de Montpellier - Val d'Aurelle
search

1. Study Identification

Unique Protocol Identification Number
NCT04015804
Brief Title
Robotic Low Rectum Anterior Resection
Acronym
GROG-R01
Official Title
European Ambispective Cohort of Rectal Cancer Patient Who Underwent Robotic Low Anterior Resection
Study Type
Interventional

2. Study Status

Record Verification Date
November 2022
Overall Recruitment Status
Active, not recruiting
Study Start Date
March 2015 (Actual)
Primary Completion Date
October 15, 2018 (Actual)
Study Completion Date
March 2025 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Institut du Cancer de Montpellier - Val d'Aurelle

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The laparoscopic approach for total mesorectal excision (L-TME) results improved short-term outcomes. However this approach has technical limitations when the pelvis is narrow and deep. Indeed there is a limited mobility of straight laparoscopic instruments and associated loss of dexterity, unstable camera view and compromised ergonomics for the surgeon. Robotic technology was developed to reduce these limitations and offers the advantages of intuitive manipulation of laparoscopic instruments with wrist articulation, a 3-dimensional field of view, a stable camera platform with zoom magnification, dexterity enhancement and an ergonomic operating environment. A major advantage of the robotic approach is the surgeon's simultaneous control of the camera and of the two or three additional instruments. This advantage facilitates traction and counter-traction. The technological advantages of robotic surgery should also allow a finer dissection in a narrow pelvic cavity.
Detailed Description
The laparoscopic approach for laparoscopic total mesorectal excision (L-TME) results improved short-term outcomes and provides a clearer intraoperative view compared with the open approach in a deep and narrow pelvis. Preliminary results from the COLOR II trial confirmed improved patient recovery and similar safety, same resection margins and completeness of resection using L-TME compared with the results achieved with open surgery.Results from the CLASICC trial supported the use of laparoscopic surgery for colorectal cancer and showed no difference between laparoscopically-assisted TME and conventional open resection at 10 years post-procedure in terms of overall survival, disease-free survival and local recurrence. Despite these positive clinical outcomes for L-TME, laparoscopic resection of rectal cancer, especially in a deep and narrow pelvis, is technically demanding and demands a long learning curve. Technical limitations include limited mobility of straight laparoscopic instruments and associated loss of dexterity, unstable camera view and compromised ergonomics for the surgeon. These limitations could explain the conversion rate which remained at 17% in the last COLOR II trial.2 In order to avoid this drawback, we have described for patients with high-risk of conversion, the trans-anal endoscopic proctectomy (TAEP) approach performed with the Transanal Endoscopic Operation (TEO) device.This trans-anal procedure is also called trans anal minimally invasive surgery (TAMIS) if a laparoscopic port is used. Robotic technology was developed to reduce these limitations and offers the advantages of intuitive manipulation of laparoscopic instruments with wrist articulation, a 3-dimensional field of view, a stable camera platform with zoom magnification, dexterity enhancement and an ergonomic operating environment. A major advantage of the robotic approach is the surgeon's simultaneous control of the camera and of the two or three additional instruments. This advantage facilitates traction and counter-traction. The technological advantages of robotic surgery should also allow a finer dissection in a narrow pelvic cavity. However, total robotic surgery for rectal cancer is still technically challenging and involves two operative fields (splenic flexure and rectum), potential collision of the robotic arms and lack of tactile feedback. Reports of robotic and laparoscopic rectal cancer surgery outcomes showed similar intraoperative results and morbidity, postoperative recovery and short-term oncologic outcomes.However, longer operation times have been described as a disadvantage of the robotic system, compared with conventional laparoscopy. On the other hand, all meta-analyses comparing robotic total mesorectal excision (R-TME) and L-TME concluded in reduction of the conversion rate. Since 2007, the rectal surgery with robotic assistance is booming. To date, seven meta-analyzes have been published. All show that the robot exceeds laparoscopy to reduce the conversion rate. The last two meta-analyzes that had gathered more than 800 patients undergoing robotic surgery have again highlighted the contribution of the robot to secure the radial margin and decrease sexual sequelae. However, there is not so far from Phase 3 randomized trial dealing with the subject. The ROLARR protocol was completed in late 2014 (Ph III laparoscopy / Robot), the first results are published in late 2015. The interest of a European multicenter ambispective (retrospective and prospective) database is fundamental because this early work suggests that the robot can make more for specific subgroups of patients, particularly in high surgical risk patients (Male, narrow pelvis, high BMI, mesorectal fat, large tumor of the anterior and middle third). The largest series of R-TME stems from the US national cancer database (965 patients operated by R-TME) and confirms a 9.5% conversion rate compared to 16.4% with L-TME (p < 0.001).

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Rectum Cancer
Keywords
cancer, rectum, robot

7. Study Design

Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
833 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Clinical database
Arm Type
Other
Intervention Type
Other
Intervention Name(s)
Clinical database
Intervention Description
Creation of an ambispective (retrospective and prospective), multicentric and European clinical database for surgery with robotic assistance in rectal cancers with implementation in France and then in Europe
Primary Outcome Measure Information:
Title
Conversion rate for robotic surgery
Time Frame
5 years
Secondary Outcome Measure Information:
Title
Anatomo-pathological curability criteria
Time Frame
5 years
Title
Median of hospitalization time
Time Frame
5 years
Title
Post-operative morbidity
Time Frame
5 years
Title
Number of robot docking
Time Frame
5 years
Title
Operating time
Time Frame
5 years

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Men or women ≥ 18 years Introducing rectal cancer, colorectal junction eligible to robotic surgery support from June 2015 Treatment Naive for this cancer Enjoying a social protection scheme (For France only) Patient followed in the participant center Exclusion Criteria: Male or female age (s) under 18 years Private person of liberty or under supervision (including guardianship) People who do not speak French (For France only) Major Nobody unable to consent Patient GROG-R01 already included in the base Patient Refusal
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Philippe Rouanet, MD
Organizational Affiliation
Institut régional du cancer de Montpellier
Official's Role
Study Chair
Facility Information:
Facility Name
UCL
City
Bruxelles
Country
Belgium
Facility Name
Hôpital Européen
City
Marseille
State/Province
Bouches Du Rhône
ZIP/Postal Code
13003
Country
France
Facility Name
Institut Paoli Calmettes
City
Marseille
State/Province
Bouches Du Rhône
ZIP/Postal Code
13273
Country
France
Facility Name
Centre François Baclesse
City
Caen
State/Province
Calvados
ZIP/Postal Code
14000
Country
France
Facility Name
Clinique Kennedy
City
Nîmes
State/Province
Gard
ZIP/Postal Code
30900
Country
France
Facility Name
Clinique Saint Jean du Languedoc
City
Toulouse
State/Province
Haute Garonne
ZIP/Postal Code
31000
Country
France
Facility Name
CHU Dupuytren
City
Limoges
State/Province
Haute Vienne
ZIP/Postal Code
87042
Country
France
Facility Name
Hôpital privé d'Anthony
City
Antony
State/Province
Hauts De Seine
ZIP/Postal Code
92160
Country
France
Facility Name
Institut régional du cancer de Montpellier
City
Montpellier
State/Province
Hérault
ZIP/Postal Code
34298
Country
France
Facility Name
Hôpital Michalon
City
Grenoble
State/Province
Isère
ZIP/Postal Code
38043
Country
France
Facility Name
CHU de Nantes
City
Nantes
State/Province
Loire Atlantique
ZIP/Postal Code
44093
Country
France
Facility Name
Institut de Cancérologie de l'Ouest
City
Saint-Herblain
State/Province
Loire Atlantique
ZIP/Postal Code
44805
Country
France
Facility Name
CHR Orléans
City
Orléans
State/Province
Loiret
ZIP/Postal Code
45100
Country
France
Facility Name
CHU de Nancy
City
Vandœuvre-lès-Nancy
State/Province
Lorraine
ZIP/Postal Code
54511
Country
France
Facility Name
Centre Oscart Lambret
City
Lille
State/Province
Nord
ZIP/Postal Code
59000
Country
France
Facility Name
Institut Gustave Roussy
City
Villejuif
State/Province
Val De Marne
ZIP/Postal Code
94800
Country
France
Facility Name
Hôpital Diaconesses
City
Paris
ZIP/Postal Code
75020
Country
France
Facility Name
Hôpital européen Georges Pompidou
City
Paris
ZIP/Postal Code
75908
Country
France
Facility Name
Centre Hospitalier-Princesse Grace
City
Monaco
ZIP/Postal Code
98012
Country
Monaco

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
23132548
Citation
Green BL, Marshall HC, Collinson F, Quirke P, Guillou P, Jayne DG, Brown JM. Long-term follow-up of the Medical Research Council CLASICC trial of conventional versus laparoscopically assisted resection in colorectal cancer. Br J Surg. 2013 Jan;100(1):75-82. doi: 10.1002/bjs.8945. Epub 2012 Nov 6.
Results Reference
background
PubMed Identifier
23395398
Citation
van der Pas MH, Haglind E, Cuesta MA, Furst A, Lacy AM, Hop WC, Bonjer HJ; COlorectal cancer Laparoscopic or Open Resection II (COLOR II) Study Group. Laparoscopic versus open surgery for rectal cancer (COLOR II): short-term outcomes of a randomised, phase 3 trial. Lancet Oncol. 2013 Mar;14(3):210-8. doi: 10.1016/S1470-2045(13)70016-0. Epub 2013 Feb 6.
Results Reference
background
PubMed Identifier
23478607
Citation
Rouanet P, Mourregot A, Azar CC, Carrere S, Gutowski M, Quenet F, Saint-Aubert B, Colombo PE. Transanal endoscopic proctectomy: an innovative procedure for difficult resection of rectal tumors in men with narrow pelvis. Dis Colon Rectum. 2013 Apr;56(4):408-15. doi: 10.1097/DCR.0b013e3182756fa0.
Results Reference
background
PubMed Identifier
25185463
Citation
Fernandez-Hevia M, Delgado S, Castells A, Tasende M, Momblan D, Diaz del Gobbo G, DeLacy B, Balust J, Lacy AM. Transanal total mesorectal excision in rectal cancer: short-term outcomes in comparison with laparoscopic surgery. Ann Surg. 2015 Feb;261(2):221-7. doi: 10.1097/SLA.0000000000000865.
Results Reference
background
PubMed Identifier
20186432
Citation
Sylla P, Rattner DW, Delgado S, Lacy AM. NOTES transanal rectal cancer resection using transanal endoscopic microsurgery and laparoscopic assistance. Surg Endosc. 2010 May;24(5):1205-10. doi: 10.1007/s00464-010-0965-6. Epub 2010 Feb 26.
Results Reference
background
PubMed Identifier
24272607
Citation
Atallah S, Martin-Perez B, Albert M, deBeche-Adams T, Nassif G, Hunter L, Larach S. Transanal minimally invasive surgery for total mesorectal excision (TAMIS-TME): results and experience with the first 20 patients undergoing curative-intent rectal cancer surgery at a single institution. Tech Coloproctol. 2014 May;18(5):473-80. doi: 10.1007/s10151-013-1095-7. Epub 2013 Nov 23.
Results Reference
background
PubMed Identifier
23292566
Citation
D'Annibale A, Pernazza G, Monsellato I, Pende V, Lucandri G, Mazzocchi P, Alfano G. Total mesorectal excision: a comparison of oncological and functional outcomes between robotic and laparoscopic surgery for rectal cancer. Surg Endosc. 2013 Jun;27(6):1887-95. doi: 10.1007/s00464-012-2731-4. Epub 2013 Jan 5.
Results Reference
background
PubMed Identifier
21228661
Citation
Kwak JM, Kim SH, Kim J, Son DN, Baek SJ, Cho JS. Robotic vs laparoscopic resection of rectal cancer: short-term outcomes of a case-control study. Dis Colon Rectum. 2011 Feb;54(2):151-6. doi: 10.1007/DCR.0b013e3181fec4fd.
Results Reference
background
PubMed Identifier
20589436
Citation
Park JS, Choi GS, Lim KH, Jang YS, Jun SH. Robotic-assisted versus laparoscopic surgery for low rectal cancer: case-matched analysis of short-term outcomes. Ann Surg Oncol. 2010 Dec;17(12):3195-202. doi: 10.1245/s10434-010-1162-5. Epub 2010 Jun 30.
Results Reference
background
PubMed Identifier
21228660
Citation
Patel CB, Ragupathi M, Ramos-Valadez DI, Haas EM. A three-arm (laparoscopic, hand-assisted, and robotic) matched-case analysis of intraoperative and postoperative outcomes in minimally invasive colorectal surgery. Dis Colon Rectum. 2011 Feb;54(2):144-50. doi: 10.1007/DCR.0b013e3181fec377.
Results Reference
background
PubMed Identifier
20526623
Citation
Bianchi PP, Ceriani C, Locatelli A, Spinoglio G, Zampino MG, Sonzogni A, Crosta C, Andreoni B. Robotic versus laparoscopic total mesorectal excision for rectal cancer: a comparative analysis of oncological safety and short-term outcomes. Surg Endosc. 2010 Nov;24(11):2888-94. doi: 10.1007/s00464-010-1134-7. Epub 2010 Jun 5.
Results Reference
background
PubMed Identifier
21066980
Citation
Popescu I, Vasilescu C, Tomulescu V, Vasile S, Sgarbura O. The minimally invasive approach, laparoscopic and robotic, in rectal resection for cancer. A single center experience. Acta Chir Iugosl. 2010;57(3):29-35. doi: 10.2298/aci1003029p.
Results Reference
background
PubMed Identifier
22215947
Citation
Lin S, Jiang HG, Chen ZH, Zhou SY, Liu XS, Yu JR. Meta-analysis of robotic and laparoscopic surgery for treatment of rectal cancer. World J Gastroenterol. 2011 Dec 21;17(47):5214-20. doi: 10.3748/wjg.v17.i47.5214.
Results Reference
background
PubMed Identifier
22151033
Citation
Trastulli S, Farinella E, Cirocchi R, Cavaliere D, Avenia N, Sciannameo F, Gulla N, Noya G, Boselli C. Robotic resection compared with laparoscopic rectal resection for cancer: systematic review and meta-analysis of short-term outcome. Colorectal Dis. 2012 Apr;14(4):e134-56. doi: 10.1111/j.1463-1318.2011.02907.x.
Results Reference
background
PubMed Identifier
22350601
Citation
Memon S, Heriot AG, Murphy DG, Bressel M, Lynch AC. Robotic versus laparoscopic proctectomy for rectal cancer: a meta-analysis. Ann Surg Oncol. 2012 Jul;19(7):2095-101. doi: 10.1245/s10434-012-2270-1. Epub 2012 Feb 16.
Results Reference
background
PubMed Identifier
22752371
Citation
Yang Y, Wang F, Zhang P, Shi C, Zou Y, Qin H, Ma Y. Robot-assisted versus conventional laparoscopic surgery for colorectal disease, focusing on rectal cancer: a meta-analysis. Ann Surg Oncol. 2012 Nov;19(12):3727-36. doi: 10.1245/s10434-012-2429-9. Epub 2012 Jul 3.
Results Reference
background
PubMed Identifier
22537895
Citation
Gonzalez Fernandez AM, Mascarenas Gonzalez JF. [Total laparoscopic mesorectal excision versus robot-assisted in the treatment of rectal cancer: a meta-analysis]. Cir Esp. 2012 Jun-Jul;90(6):348-54. doi: 10.1016/j.ciresp.2012.03.004. Epub 2012 Apr 24. Spanish.
Results Reference
background
PubMed Identifier
22438060
Citation
Ortiz-Oshiro E, Sanchez-Egido I, Moreno-Sierra J, Perez CF, Diaz JS, Fernandez-Represa JA. Robotic assistance may reduce conversion to open in rectal carcinoma laparoscopic surgery: systematic review and meta-analysis. Int J Med Robot. 2012 Sep;8(3):360-70. doi: 10.1002/rcs.1426. Epub 2012 Mar 22.
Results Reference
background
PubMed Identifier
24565506
Citation
Xiong B, Ma L, Zhang C, Cheng Y. Robotic versus laparoscopic total mesorectal excision for rectal cancer: a meta-analysis. J Surg Res. 2014 May 15;188(2):404-14. doi: 10.1016/j.jss.2014.01.027. Epub 2014 Jan 22.
Results Reference
background
PubMed Identifier
20701545
Citation
Son GM, Kim JG, Lee JC, Suh YJ, Cho HM, Lee YS, Lee IK, Chun CS. Multidimensional analysis of the learning curve for laparoscopic rectal cancer surgery. J Laparoendosc Adv Surg Tech A. 2010 Sep;20(7):609-17. doi: 10.1089/lap.2010.0007.
Results Reference
background
PubMed Identifier
25101602
Citation
Kim HJ, Choi GS, Park JS, Park SY. Multidimensional analysis of the learning curve for robotic total mesorectal excision for rectal cancer: lessons from a single surgeon's experience. Dis Colon Rectum. 2014 Sep;57(9):1066-74. doi: 10.1097/DCR.0000000000000174.
Results Reference
background
PubMed Identifier
23242270
Citation
Jimenez-Rodriguez RM, Diaz-Pavon JM, de la Portilla de Juan F, Prendes-Sillero E, Dussort HC, Padillo J. Learning curve for robotic-assisted laparoscopic rectal cancer surgery. Int J Colorectal Dis. 2013 Jun;28(6):815-21. doi: 10.1007/s00384-012-1620-6. Epub 2012 Dec 15.
Results Reference
background
PubMed Identifier
24562546
Citation
Kuo LJ, Lin YK, Chang CC, Tai CJ, Chiou JF, Chang YJ. Clinical outcomes of robot-assisted intersphincteric resection for low rectal cancer: comparison with conventional laparoscopy and multifactorial analysis of the learning curve for robotic surgery. Int J Colorectal Dis. 2014 May;29(5):555-62. doi: 10.1007/s00384-014-1841-y. Epub 2014 Feb 23.
Results Reference
background
PubMed Identifier
20607559
Citation
Baek JH, Pastor C, Pigazzi A. Robotic and laparoscopic total mesorectal excision for rectal cancer: a case-matched study. Surg Endosc. 2011 Feb;25(2):521-5. doi: 10.1007/s00464-010-1204-x. Epub 2010 Jul 7.
Results Reference
background
PubMed Identifier
19688388
Citation
Park YA, Kim JM, Kim SA, Min BS, Kim NK, Sohn SK, Lee KY. Totally robotic surgery for rectal cancer: from splenic flexure to pelvic floor in one setup. Surg Endosc. 2010 Mar;24(3):715-20. doi: 10.1007/s00464-009-0656-3. Epub 2009 Aug 18.
Results Reference
background
PubMed Identifier
25405559
Citation
Speicher PJ, Englum BR, Ganapathi AM, Nussbaum DP, Mantyh CR, Migaly J. Robotic Low Anterior Resection for Rectal Cancer: A National Perspective on Short-term Oncologic Outcomes. Ann Surg. 2015 Dec;262(6):1040-5. doi: 10.1097/SLA.0000000000001017.
Results Reference
background
PubMed Identifier
25361216
Citation
Tuech JJ, Karoui M, Lelong B, De Chaisemartin C, Bridoux V, Manceau G, Delpero JR, Hanoun L, Michot F. A step toward NOTES total mesorectal excision for rectal cancer: endoscopic transanal proctectomy. Ann Surg. 2015 Feb;261(2):228-33. doi: 10.1097/SLA.0000000000000994.
Results Reference
background
PubMed Identifier
24316953
Citation
Wolthuis AM, de Buck van Overstraeten A, D'Hoore A. Dynamic article: transanal rectal excision: a pilot study. Dis Colon Rectum. 2014 Jan;57(1):105-9. doi: 10.1097/DCR.0000000000000008.
Results Reference
background
PubMed Identifier
22874608
Citation
Dumont F, Goere D, Honore C, Elias D. Transanal endoscopic total mesorectal excision combined with single-port laparoscopy. Dis Colon Rectum. 2012 Sep;55(9):996-1001. doi: 10.1097/DCR.0b013e318260d3a0.
Results Reference
background
PubMed Identifier
21742663
Citation
Zorron R, Phillips HN, Coelho D, Flach L, Lemos FB, Vassallo RC. Perirectal NOTES access: "down-to-up" total mesorectal excision for rectal cancer. Surg Innov. 2012 Mar;19(1):11-9. doi: 10.1177/1553350611409956. Epub 2011 Jul 7.
Results Reference
background

Learn more about this trial

Robotic Low Rectum Anterior Resection

We'll reach out to this number within 24 hrs